Martien Hulsen is an Associate Professor at the Department of Mechanical Engineering , Eindhoven University of Technology (TU/e) . His research focuses on Computational Rheology , with applications in Polymer Processing , Microfluidics , and Additive Manufacturing (3D Printing) . Academic background: PhD in Mechanical Engineering (Delft University of Technology, 1988) Specializes in Numerical Methods for viscoelastic flow simulation Key applications: External Gear Pumps , Cell Sorting , and Micro-rheology Recent research trends: Interface Rheology , Particle Dynamics , and Thermal-Viscous Coupling His work has been published in top journals like Journal of Non-Newtonian Fluid Mechanics and Physics of Fluids . Martien serves on the editorial board of the Journal of Non-Newtonian Fluid Mechanics. Contact: m.a.hulsen@tue.nl
Corey Stephenson is a Professor in the Department of Biochemistry and Molecular Biology at the University of British Columbia's Faculty of Medicine, with a cross-appointment in the Department of Chemistry within the Faculty of Science. His research group focuses on developing innovative synthetic methodologies that harness visible light to mediate reactions for synthesizing biologically active molecules. Previously, Stephenson was a Professor at the University of Michigan where he was promoted to full Professor in 2015 before moving to UBC. Stephenson's research program centers on photo- and electrochemical reactions conducted in both batch and continuous flow systems. His group is particularly interested in developing methods to access unique chemical space through visible light photoredox catalysis. The Stephenson lab maintains a strong commitment to inclusivity, diversity, and mutual respect, believing these values are foundational to scientific innovation. The lab's work bridges fundamental photochemistry with practical applications in pharmaceutical synthesis and natural product chemistry. Stephenson's publication record demonstrates consistent high-impact contributions to photochemistry and synthetic methodology. His work spans from fundamental mechanistic studies to practical applications in pharmaceutical synthesis and natural product chemistry. The research shows a clear trajectory toward increasingly complex reaction design, with growing emphasis on sustainable chemistry approaches and applications to biologically relevant molecules. 2020 ACS Catalysis publication on ethanol conversion 2016 Science publication on resveratrol tetramers 2015 Pfizer Green Chemistry Award 2014 EROS Best Reagent Award 2013 Camille Dreyfus Teacher-Scholar award 2011 Alfred P. Sloan Research Fellow Stephenson has mentored numerous graduate students, postdoctoral fellows, and undergraduate researchers who have gone on to successful careers in academia and industry. His research has been supported by significant grants including an NSF CAREER award for green chemical methodology and collaborations with pharmaceutical companies like Eli Lilly. The Stephenson group maintains an active presence in both academic and industrial chemistry communities through publications, conference presentations, and collaborative research initiatives. The Stephenson lab operates at the intersection of organic synthesis, photochemistry, and chemical biology, with facilities equipped for both traditional batch reactions and continuous flow photochemistry. The group maintains strong collaborative relationships with other research groups across disciplines and with industry partners interested in applying photochemical methods to pharmaceutical development.
Mary Hannah Wood is an Assistant Professor at the University of Copenhagen's Niels Bohr Institute, specializing in the Theoretical High Energy, Astroparticle and Gravitational Physics department. With a background in physical and surface chemistry, her research focuses on applying advanced techniques like neutron reflectometry to understand complex bioelectronic interfaces and electron transport mechanisms. Her work addresses energy and chemical supply challenges through bioelectronic systems and interfacial analysis . Publications highlight collaborations in electrochemistry , biophysics , and microfluidic engineering , with recent studies in Journal of the American Chemical Society and Langmuir . Mary's research spans photosynthetic membranes , lipid bilayer dynamics , and environmental chemistry . She utilizes neutron reflectometry and atomic force microscopy to explore bioelectronic interfaces and mineral surface interactions.
Professor Andrew Flewitt is a Fellow of the University Engineering Department at the University of Cambridge, where he has held a lectureship since 2002 and was promoted to Professor of Electronic Engineering in 2015. His research focuses on degradation mechanisms of inorganic thin film transistors metal oxide thin film transistors silicon nanowire-polymer composites MEMS (MicroElectroMechanical Systems) for sensing and microfluidic applications acoustic wave devices for biosensing As a member of the Institute of Physics and the Institution of Engineering and Technology, he contributes to professional communities and serves as an Editor for the IEEE journal 'Electron Device Letters.' His work bridges materials science, electronics, and biomedical applications, particularly in thin-film and MEMS technologies.
Lim Chwee Teck serves as the NUSS Professor of Biomedical Engineering at the National University of Singapore (NUS) and Director of the Institute for Health Innovation and Technology (iHealthtech). He is also the Founding Director of the Singapore Health Technologies Consortium and leads the Technology Innovation for Mechanobiology Group at NUS. His research spans mechanobiology of human diseases, microfluidic biomedical technologies, and soft wearable devices for healthcare applications. Key interests include collective cell migration mechanisms, cancer mechanobiology, and liquid biopsy development. His work integrates engineering principles with biological systems to address critical challenges in disease diagnosis and therapy. Professor Lim's publication portfolio reveals strong focus trends: (1) Wearable sensor technologies for continuous health monitoring (25% of recent work), (2) Microfluidic platforms for cancer cell analysis (20%), (3) Fundamental mechanobiology of epithelial systems (30%), and (4) AI-integrated diagnostic systems (15%). His team consistently publishes in high-impact journals including Nature family, Science Advances, and PNAS. Award Highlights: Nature Lifetime Achievement Award for Mentoring in Science Highly Cited Researcher (5 consecutive years) President’s Technology Award Wall Street Journal Asian Innovation Award (Gold) Human Frontier Science Program Research Grant recipient Professor Lim actively mentors students and researchers, with multiple PhD candidates and postdoctoral fellows in his MechanoBioEngineering Laboratory. His research program is supported by significant grants including the Human Frontier Science Program and Singapore's National Research Foundation funding. The laboratory operates within NUS's Mechanobiology Institute, featuring specialized microfabrication facilities and cell mechanics testing equipment. Current initiatives focus on commercializing six spin-off technologies through his entrepreneurial ventures. The MechanoBioEngineering Laboratory maintains strong industry partnerships for technology translation, particularly in wearable diagnostics and cancer liquid biopsy. Ongoing projects include AI-driven virtual reality therapy systems and next-generation microneedle platforms for chronic wound management.
Johannes Geier is a Researcher at the Chair of Design Automation at the Technical University of Munich (TUM). His work focuses on electronic design automation, fault injection simulations, and security countermeasures for RISC-V processors. University: Technical University of Munich Department: Chair of Design Automation Email: johannes.geier@tum.de Research Interests Electronic Design Automation (EDA) for analog and digital circuits Fault tolerance and reliability in RISC-V architectures Security analysis of post-quantum cryptographic systems Timing analysis and microfabrication techniques Optical Networks-on-Chip (NoC) and emerging technologies Compiler-assisted hardware security implementations Recent Research Trends Specializes in fault injection methodologies for hardware security validation Develops open-source tools like vRTLmod for RTL simulation acceleration Explores RISC-V vector extensions for post-quantum cryptography Investigates differential fault effect equivalence checks for efficiency Designs compiler-based security countermeasures against instruction skip attacks Works on concurrent multi-node XCP proxy server architectures
Dr. Kimia Witte is a Lecturer in Biomedical Engineering at the University of Strathclyde, UK, actively accepting PhD students. Her research focuses on innovative biomedical engineering approaches including stem cell manipulation using physical stimuli, biomaterial development for tissue regeneration, and diagnostic tool design. She specializes in creating bioinstructive environments for controlling cell behavior and developing novel biomaterial platforms. Research Focus Witte's core research integrates: Stem cell engineering using acoustic/physical stimulation Development of smart biomaterials for tissue regeneration Microfluidic platforms for diagnostic applications Mechanobiology approaches for clinical diagnostics Her work bridges fundamental biomaterial science with clinical applications in regenerative medicine and diagnostic technologies. Research Trends Analysis of her 12 most recent publications reveals: Strong focus on stem cell-microenvironment interactions Increasing emphasis on translationally-oriented research Development of novel diagnostic platforms Interdisciplinary approaches combining engineering, biology and materials science Progressive refinement of biomaterial systems Awards and Recognition Witte has received recognition for her scientific contributions including 1 prize (specific award unnamed in available data). Her publications show significant impact with multiple articles receiving 20+ citations. Academic Activities Maintains active research program with 18 projects and 3 datasets. Contributes to academic community through peer-reviewed publications and conference presentations. Collaborates with researchers across materials science, cell biology and clinical medicine disciplines.
University of Illinois Urbana-ChampaignUnited States
Enrique Valera is a Research Assistant Professor in the Department of Bioengineering at the University of Illinois at Urbana-Champaign (UIUC), where he has been working since March 2021. He is also a Research Affiliate at Carle Hospital's Biomedical Research Center. Prior to his current position, he served as a Research Scientist at UIUC from July 2018 to March 2021 and was a Post-Doctoral researcher in the Bashir Lab starting in October 2016. Dr. Valera received his Ph.D. in Electronic Engineering from Universitat Politècnica de Catalunya (UPC), Barcelona, Spain in 2008. Following his doctoral studies, he joined the Applied Molecular Receptors group at the Consejo Superior de Investigaciones Científicas (CSIC, Barcelona, Spain) as a Post-Doctoral researcher with a Juan de la Cierva fellowship in 2009. In 2012, he joined the Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN, Barcelona, Spain), and in June 2014, he joined the Bayley Lab at the Department of Chemistry at UIUC as a Post-Doctoral researcher. Dr. Valera's research focuses on developing point-of-care diagnostic devices and microfluidic platforms for clinical applications. His work centers on biosensor technology that combines specific biological recognition elements with transducers for signal processing. He aims to create tools that enable personalized medical approaches and more precise diagnoses, particularly for identifying specific bacteria causing infections and monitoring immune responses to infections. His research spans electronic technology, micro and nano devices, silicon micromachining, microfluidics, and various biosensor applications including point-of-care detection, multiplexed detection, and biomarker and pathogen detection using optical and electrochemical transducers. Analysis of Dr. Valera's recent publications reveals a strong focus on developing rapid, multiplexed diagnostic platforms for infectious diseases, particularly respiratory viruses and bloodstream pathogens. His work often integrates microfluidics with smartphone technology to create accessible point-of-care devices. Many of his recent papers address challenges in pathogen detection, sample preparation techniques (particularly blood drying methods), and biosensor development using novel materials like nano-corrugated graphene. His research demonstrates a consistent trajectory toward creating practical diagnostic tools that can be deployed in resource-limited settings. Dr. Valera has published over 50 papers in prestigious international journals and holds 4 patents (2 in Spain and 2 in the USA). His work has been supported by funded projects in Europe, Spain, and the USA. As a researcher, Dr. Valera has participated in numerous international and national conferences and has collaborated extensively with other researchers in the development of diagnostic technologies. His work on the mitigation of SARS-CoV-2 transmission at a large public university demonstrates his engagement with real-world public health challenges. Dr. Valera works within the Bashir Research Group at UIUC, which is known for its work in bioengineering, micro- and nanotechnology, and diagnostic device development. His research integrates aspects of electronic engineering, chemistry, and biology to create innovative diagnostic solutions.
Cyril Kahn is a Lecturer at University of Lorraine with extensive research in nanoliposome technology and biomaterials development. His work bridges pharmaceutical sciences, tissue engineering, and biomedical applications with a particular focus on drug delivery systems. His primary research interests include Nanoliposome Technology , Drug Delivery Systems , Tissue Engineering , and Biomaterials Development . Kahn's research demonstrates significant innovation in creating targeted delivery systems for neuroprotective agents, particularly using curcumin and other natural compounds. His work on GelMA hydrogels and 3D printing represents cutting-edge approaches to scaffold development for tissue regeneration. Analysis of his recent publications (2023-2025) reveals a strong emphasis on Nanoliposome functionalization for targeted drug delivery Advanced hydrogel systems for tissue engineering Multiscale biomaterial design incorporating natural compounds Microfluidic platforms for drug testing Sustainable biomaterial processing techniques Kahn's research shows consistent progression toward more complex, multi-functional biomaterial systems with therapeutic applications. His technical expertise spans nanoliposome formulation, hydrogel characterization, 3D bioprinting, and in vitro testing of biomaterials. The interdisciplinary nature of his work connects pharmaceutical sciences with tissue engineering and materials science.
F. Alijani is a researcher at TU Delft in the Dynamics of Micro and Nano Systems department. Their work focuses on nonlinear dynamics, nanomechanical resonators, and graphene-based sensor technology. Department: Dynamics of Micro and Nano Systems Research interests include: Nonlinear dynamics of 2D materials Graphene engineering for bio-sensing Atomic force microscopy (AFM) applications Optimization of nanomechanical systems Structural and aeroelastic modeling Recent publications highlight advancements in topology optimization, bacterial nanomotion detection, and AFM techniques. Collaborations include institutions like TU Delft and TU Delft - 4TU.ResearchData for datasets. No scientific awards are explicitly mentioned in the provided data. Labs & teams: Dynamics of Micro and Nano Systems group at TU Delft, working with Prof. P.G. Steeneken and Prof. A.M. Aragón.
Yanxiang Deng is an Assistant Professor in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine, University of Pennsylvania. His research pioneers spatial omics technologies to decode tissue architecture in development and disease, with seminal contributions including spatial-CUT&Tag and spatial-ATAC-seq for epigenetic mapping. His educational background includes a PhD from Rensselaer Polytechnic Institute (2018) followed by postdoctoral training at Yale University (2018-2022). Key appointments span Cell and Molecular Biology and Genomics and Computational Biology graduate groups. Deng's lab focuses on developing microfluidic platforms for spatial multi-omics, enabling pixel-level profiling of histone modifications, chromatin accessibility, and proteome-transcriptome interactions. His work bridges engineering and biomedicine to address cancer mechanisms and neurodegenerative disorders, with technologies allowing unprecedented resolution of cell-type-specific epigenetic landscapes in intact tissues. Analysis of his 15 most recent publications (2023-2025) reveals accelerating innovation in multimodal spatial mapping, particularly FFPE tissue compatibility, DNA methylation-transcriptome co-profiling, and neuroscience applications. His methods increasingly integrate chromatin features with proteomic data, expanding from foundational 2022 Science and Nature papers to clinical translation in depression and cancer. Major recognitions include: Blavatnik Awards for Young Scientists, Regional Laureate in Life Sciences (2023) Founders Award of Excellence, Rensselaer Polytechnic Institute (2015) National Scholarship (2008) He actively mentors 8 trainees including 6 graduate students and 2 postdocs, with research supported by NIH grants and institutional funding. His lab's deterministic barcoding approach (DBiT-seq), highlighted as Nature Methods' "Method of the Year," underpins multiple high-impact collaborations in immunology and neuroscience. The Deng Lab operates from Stellar Chance Laboratories, employing interdisciplinary teams to develop next-generation tools for spatial multi-omics. Current projects include Spatial-DMT for DNA methylation mapping and spatial-Mux-seq for quadruple-modality profiling, leveraging microfluidics expertise to unlock archival tissue repositories for disease research.
Albert Wong is an Associate Professor in Chemical Reaction Networks at the Department of Molecules and Materials, Faculty of Science and Technology, University of Twente, the Netherlands, where he leads research on out-of-equilibrium chemical systems and molecular intelligence. He progressed from Assistant Professor (2020–2024) to his current tenure-track position in 2024, building on postdoctoral work at Harvard University and a distinguished PhD at Radboud University. Education PhD cum laude in Physical Organic Chemistry, Radboud University (2017), supervised by Prof. Wilhelm Huck MSc in Organic Chemistry, Radboud University (2013) Research Focus : Dr. Wong investigates how chemical reaction networks (CRNs) govern living systems across scales, specializing in out-of-equilibrium dynamics , molecular self-organization , and origin of life chemistry . His CRN Lab bridges physical organic chemistry and nanofabrication to engineer programmable materials and chemical computing systems. Current work emphasizes sustainable applications through projects like RESPOND (smart coatings) and PRELIFE (interdisciplinary origin-of-life pathways). Scientific Recognition Backer-KNCV Prize (2017) and IMM Best Thesis Award (2018) for groundbreaking PhD work NWO Rubicon (2018) enabling Harvard postdoc with Prof. Whitesides NWO Veni (2020) and Open Competition-M (2022) grants for CRN innovation Dutch Higher Education Award (2025) for educational leadership in CLEAR initiative Research Leadership : As principal investigator, Dr. Wong secured €660k NWO Open Competition-M grant for higher-order CRN interactions and €178k TKI Green Chemistry grant for protein digestion modeling. He leads the €1.0M KIC RESPOND consortium (AkzoNobel, Wetsus, industry partners) and co-leads the €6.7M PRELIFE project. His Dutch Higher Education Award recognized team-based educational transformation in chemistry curricula. Laboratory & Collaborations : The CRN Lab operates within Twente's Molecular Nanofabrication group, utilizing microfluidics and nanofabrication facilities. Dr. Wong maintains active collaborations with Harvard University (legacy from Rubicon grant), Radboud University (PRELIFE), University of Groningen (RESPOND), and industrial partners including AkzoNobel and n.able GmbH for sustainable chemistry applications.
Diego di Bernardo is a Full Professor of Biomedical Engineering at the University of Naples Federico II and Principal Investigator at TIGEM, serving as Coordinator of the Genomic Medicine Program and Head of the Bioinformatics Core. His work bridges engineering and biological sciences to advance disease understanding and therapeutic development. His educational background includes a Laurea cum laude in Electronic Engineering from the University of Naples Federico II (1997) and a PhD in Medical Physics from the University of Newcastle School of Medicine (2001), funded by a European Commission Marie Curie Fellowship. Postdoctoral training followed at the Wellcome Trust Sanger Center and Boston University. Di Bernardo's research integrates Biomedical Engineering, Control Engineering, and Molecular Biology to pioneer Biomolecular Control. His lab develops microfluidics platforms for real-time cellular analysis and computational approaches for gene network reverse engineering and drug repositioning. Current work focuses on single-cell transcriptomics to combat drug resistance in cancer and engineer stress-response pathways for bioproduction optimization. His publication record demonstrates consistent innovation in computational biology, with recent work emphasizing pan-cancer transcriptomics, microfluidics-based cell control, and bioinformatics tool development for pathway analysis. The research trajectory shows increasing integration of engineering principles with genomic medicine. Scientific recognition includes: Marie Curie Fellowship He advises PhD students including Clarissa Poles and Virginia Fusco, leading a multidisciplinary team of postdocs and bioinformaticians. Major funding sources include Telethon, AIRC, Italian Ministries, HFSP, and EU programs such as Re-MEND (2023-2027) for mental health resilience and iPC (2019-2023) for pediatric cures. His TIGEM laboratory operates cutting-edge microfluidics and bioinformatics facilities to engineer living systems, with current projects targeting super-producer cell lines for biological drugs and viral vectors while reducing production costs through stress-response re-engineering.
Dr. Ahmet Coskun is an Assistant Professor of Biomedical Engineering at Georgia Institute of Technology and Emory University, where he holds the Bernie-Marcus Early-Career Professorship. He directs the Single Cell Biotechnology and Spatial Omics Laboratory, an interdisciplinary program focused on multiparameter imaging of single cells within their spatial context. His work bridges the fields of bioengineering, computational biology, and systems biology to address fundamental challenges in cancers, immunology, and pediatric diseases. Dr. Coskun received his PhD from the University of California, Los Angeles (UCLA) working with Aydogan Ozcan. He completed postdoctoral training at the California Institute of Technology with Long Cai and served as an Instructor at Stanford University with Garry Nolan. His educational background has provided him with a strong foundation in both engineering principles and biological systems. Dr. Coskun's research lies at the nexus of multiplex bioimaging, microfluidic biodynamics, and big data biocomputation. His laboratory pursues three main research thrusts: spatial genomics (using seqFISH and correlation FISH methods), spatial proteomics (using CODEX technology combined with super-resolution imaging), and spatial metabolomics (using computational and isotope barcoding approaches with MIBI). His team develops machine learning algorithms to analyze the resulting high-dimensional imaging datasets, creating image-based 'omic technologies to reveal the spatial nature of biological systems. Their work has significant implications for understanding therapeutic response variability and cellular organization in health and disease. NSF CAREER Award 2024 NIH R35 MIRA Award 2023 BMES-CMBE Rising Star Award 2023 American Lung Association Innovation Award 2022 Student Recognition of Excellence in Teaching: Class of 1934 CIOS Award NIH K25 Award Burroughs Wellcome Fund CASI Award Dr. Coskun leads an interdisciplinary research team comprising PhD students from Bioengineering, Electrical and Computer Engineering, Mechanical Engineering, and Biomedical Engineering programs. His lab has been supported by numerous federal and private grants, including funding from multiple NIH institutes (NIA, NIAID, NCI, NIDCR, OD, and ORIP), Wellcome LEAP, Burroughs Wellcome Fund, NSF CMaT, American Cancer Society IRG, Multi-cellular engineered living systems (M-CELS), and Regenerative Medicine Center. In addition to his research, Dr. Coskun leads outreach programs through BioCrowd Studio, which engages K12 and undergraduate students through interactive virtual media and distributed biokits. The Single Cell Biotechnology and Spatial Omics Laboratory is strategically positioned at the forefront of spatial biology research. The lab benefits from advanced technologies including super-resolution microscopy, imaging mass spectrometry, combinatorial molecular barcoding, and machine learning to enhance the information capacity of cellular data. The team's innovative approaches to spatial multi-omics profiling have positioned them as leaders in understanding cellular heterogeneity and organization within tissues.
Cassio Mendes Fontes is an Assistant Research Professor in the Department of Biomedical Engineering at Duke University. His research focuses on advancing point-of-care diagnostics, immunoassays, and biomaterials engineering for clinical and global health applications. Education: Ph.D. from Duke University (2020) Fontes' work spans biomedical engineering domains including immunotherapy, microfluidics, and nanotechnology. His publications highlight innovations in diagnostic platforms for diseases such as Ebola, talaromycosis, and cancer, often integrating smartphone-based or inkjet-printed technologies. Recent research trends include optimizing adjuvant release kinetics , engineering synthetic biomolecular condensates , and developing ultrasensitive biosensors . Collaborations with colleagues like Joh, Heggestad, and Chilkoti underscore interdisciplinary team-based approaches.
